Nanospugna ‘cage’ toxin vaccine

(ANSAmed) – Rome, December 1 – works in mice the first vaccine of nanospugne, a ‘molecular’ cage designed to educate the immune system and neutralize one of the most insidious bacteria: drug-resistant staph. The work carried out by researchers at the University of California in San Diego and presented in nature nanotechnology could open the door to a new type of vaccine against antibiotic-resistant infections. The mice showed a high rate of effectiveness. All rights reserved